Effect of Nicotinic Acid in Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial

Condition:   Migraine Prophylaxis Interventions:   Drug: Nicotinic Acid 500 MG Extended Release Oral Tablet;   Drug: Nicotinic Acid 1000 MG Extended Release Oral Tablet;   Other: Placebo Sponsor:   Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials